Under her leadership, the Clinical and Research Institute on Addictions will embody new strategies, such as AI, to advance addiction research, prevention and treatment.

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

GLP-1 agonist medications such as Ozempic have been game changers in the treatment of obesity and diabetes. Recently, a new study found evidence that Ozempic may be a promising medicine for ...